EDGAR Filing Documents for 0001477932-17-003735

Form 5 - Annual statement of changes in beneficial ownership of securities:

SEC Accession No. 0001477932-17-003735

Filing Date

2017-08-08

Accepted

2017-08-08 16:15:58

Documents

Period of Report

2017-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 5	form5.html	5
1	FORM 5	form5.xml	5	5555
	Complete submission text file	0001477932-17-003735.txt		7099

Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915

Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 978-921-4125

Innovation Pharmaceuticals Inc. (Issuer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 CUMMINGS CENTER, SUITE 151-B BEVERLY MA 01915

Business Address

Type: 5 | Act: 34 | File No.: 001-37357 | Film No.: 171014933